Functional Connectivity of the Interoceptive Network in RLS
Launched by UNIVERSITY HOSPITAL, BORDEAUX · May 23, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying Restless Legs Syndrome (RLS), a condition that causes an overwhelming urge to move the legs, especially when at rest. The researchers believe that RLS may be related to how the brain processes our internal feelings and sensations, particularly in a part of the brain called the insular cortex. By comparing patients with RLS to healthy individuals, the study aims to understand how different brain functions might affect RLS symptoms and daily behaviors. Participants will be monitored over two weeks using mobile technologies to track their symptoms and sleep patterns, providing valuable insights into the relationship between brain function and RLS.
To be eligible for this trial, participants need to be between 18 and 70 years old and have a confirmed diagnosis of idiopathic RLS. They should not have significant psychiatric conditions, chronic pain unrelated to RLS, or other serious health issues that could interfere with the study. Participants will be asked to provide informed consent before joining the study. Throughout the trial, those involved can expect a comprehensive evaluation of their symptoms, brain activity, and daily routines, contributing to a better understanding of RLS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person aged from 18 to 70 years
- • Only for the patients : ny patient with a diagnosis of idiopathic RLS based on medical history and the presence of the 5 RLS diagnostic criteria
- • Normal clinical examination
- • Person affiliated or benefiting from a social security scheme
- • Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and prior to any review required by the research).
- Exclusion Criteria:
- • Any significant psychiatric illness or mood disorder
- • History or presence of chronic pain other than that associated with RLS, history of epilepsy or serious head injury, history of peripheral neuropathy, diabetes
- • Clinically significant sleep apnea, narcolepsy, or any secondary causes of RLS (e.g. chronic renal failure/hemodialysis, pregnancy)
- • Other active clinically significant illness, including unstable cardiovascular, or neoplasic pathology which could interfere with the study conduct or interfere with study assessments or compromise the study participation
- • Contra-indication to MRI (pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body, claustrophobia or refusing MRI)
- • Pregnant or breastfeeding woman
- • Persons referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent).
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Patients applied
Trial Officials
Imad Marc Antoine GHORAYEB, MD, PhD
Principal Investigator
University Hospital, Bordeaux
Gwénaëlle CATHELINE, PhD
Study Chair
Université de Bordeaux - INCIA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported